Literature DB >> 10639435

Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

M J Gomez1, B Maras, A Barca, R La Valle, D Barra, A Cassone.   

Abstract

In the search of the antigenic determinants of a 65-kDa mannoprotein (MP65) of Candida albicans, tryptic fragments of immunoaffinity-purified MP65 preparations were tested for their ability to induce lymphoproliferation of human peripheral blood mononuclear cells (PBMC). Five major peptides (T1 to T5) were shown to induce a vigorous proliferation of PBMC from the majority of the eight healthy human subjects tested. With the use of synthetic peptides, critical amino acid sequences of the two most immunoactive (T1 and T2) peptides were determined. Similar to what was found for the MP65 molecule, no PBMC multiplication was induced by the antigenic peptides in cultures of naive cord blood cells. The amino acid sequence analysis of tryptic and chymotryptic peptides of MP65 demonstrated a substantial homology with the deduced sequences of two cell wall proteins of Saccharomyces cerevisiae, encoded by the genes YRM305C and YGR279C. However, the antigenic peptides were those showing the least similarity with the corresponding regions of the above proteins. In particular, the lymphoproliferation-inducing sequence of the T1 peptide scored only 20% identity with the homologous regions of S. cerevisiae proteins. Besides disclosing the amino acid sequence of MP65, this study provides an initial characterization of some of its antigenic determinants, as well as of synthetic peptides of potential use to detect specific immune responses against MP65, a major target of anticandidal cell-mediated immunity in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639435      PMCID: PMC97194          DOI: 10.1128/IAI.68.2.694-701.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Limited N-terminal sequence analysis.

Authors:  P Matsudaira
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

Authors:  R D Nelson; N Shibata; R P Podzorski; M J Herron
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

Review 3.  Fungal cell adhesion molecules in Candida albicans.

Authors:  G Tronchin; J P Bouchara; V Annaix; R Robert; J M Senet
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

4.  Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans.

Authors:  A Torosantucci; C Palma; M Boccanera; C M Ausiello; G C Spagnoli; A Cassone
Journal:  J Gen Microbiol       Date:  1990-11

Review 5.  Candida cell wall mannan: a polysaccharide with diverse immunologic properties.

Authors:  J E Domer
Journal:  Crit Rev Microbiol       Date:  1989       Impact factor: 7.624

6.  Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues.

Authors:  N Shibata; M Arai; E Haga; T Kikuchi; M Najima; T Satoh; H Kobayashi; S Suzuki
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 7.  The role of hsp90 in fungal infection.

Authors:  R Matthews; J Burnie
Journal:  Immunol Today       Date:  1992-09

8.  Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects.

Authors:  I Quinti; C Palma; E C Guerra; M J Gomez; I Mezzaroma; F Aiuti; A Cassone
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

Review 9.  Candida and AIDS: evidence for protective antibody.

Authors:  R Matthews; J Burnie; D Smith; I Clark; J Midgley; M Conolly; B Gazzard
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

10.  Biochemical and antigenic characterization of mannoprotein constituents released from yeast and mycelial forms of Candida albicans.

Authors:  A Torosantucci; M J Gomez; C Bromuro; I Casalinuovo; A Cassone
Journal:  J Med Vet Mycol       Date:  1991
View more
  10 in total

1.  Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.

Authors:  Donatella Pietrella; Cristina Corbucci; Stefano Perito; Giovanni Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.

Authors:  Donatella Pietrella; Rosanna Mazzolla; Patrizia Lupo; Lucia Pitzurra; Maria Jesus Gomez; Robert Cherniak; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Generation of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to Candida albicans.

Authors:  R La Valle; S Sandini; M J Gomez; F Mondello; G Romagnoli; R Nisini; A Cassone
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones.

Authors:  R Nisini; G Romagnoli; M J Gomez; R La Valle; A Torosantucci; S Mariotti; R Teloni; A Cassone
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  A Candida albicans mannoprotein deprived of its mannan moiety is efficiently taken up and processed by human dendritic cells and induces T-cell activation without stimulating proinflammatory cytokine production.

Authors:  Donatella Pietrella; Patrizia Lupo; Anna Rachini; Silvia Sandini; Alessandra Ciervo; Stefano Perito; Francesco Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

6.  The MP65 gene is required for cell wall integrity, adherence to epithelial cells and biofilm formation in Candida albicans.

Authors:  Silvia Sandini; Annarita Stringaro; Silvia Arancia; Marisa Colone; Francesca Mondello; Susanna Murtas; Antonietta Girolamo; Nicolina Mastrangelo; Flavia De Bernardis
Journal:  BMC Microbiol       Date:  2011-05-16       Impact factor: 3.605

7.  Identification of Candida Species Using MP65 Gene and Evaluation of the Candida albicans MP65 Gene Expression in BALB/C Mice.

Authors:  Farahnaz Bineshian; Mohammad Hossien Yadegari; Zohre Sharifi; Mohammadreza Akbari Eidgahi; Reza Nasr
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

Review 8.  The role of the cell wall in fungal pathogenesis.

Authors:  David M Arana; Daniel Prieto; Elvira Román; César Nombela; Rebeca Alonso-Monge; Jesús Pla
Journal:  Microb Biotechnol       Date:  2008-11-26       Impact factor: 5.813

9.  Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation.

Authors:  Michael D Keller; Catherine M Bollard
Journal:  Immunotargets Ther       Date:  2014-06-18

10.  Protein markers for Candida albicans EVs include claudin-like Sur7 family proteins.

Authors:  Charlotte S Dawson; Donovan Garcia-Ceron; Harinda Rajapaksha; Pierre Faou; Mark R Bleackley; Marilyn A Anderson
Journal:  J Extracell Vesicles       Date:  2020-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.